论文部分内容阅读
我院1989年1月～1993年8月对46例大肝癌患者(肿瘤直径≥5cm)行手术切除后随机分成术后栓塞化疗(TAE)、术后单纯化疗(TAC)和术后无栓塞或化疗(对照组)3组,以探讨提高大肝癌切除术后远期疗效的有效疗法。 材料与方法 1.一般资料 本组病人共46例,术前有腹痛、腹胀者26例,无症状20例;术前均行CT检查确定肝癌的具体部位及大小。患者随机分成3组:TAE组18例,男15例,女3例,年龄21～68岁,平均39.6岁;癌肿位于肝左叶3例,肝右前叶3例,肝右后叶6
From January 1989 to August 1993, 46 patients with large HCC (tumor diameter ≥5cm) were randomly divided into postoperative embolization chemotherapy (TAE), postoperative chemotherapy alone (TAC), and postoperative embolization. Chemotherapy (control group) 3 groups to explore the effective therapy to improve the long-term effect after resection of large hepatocellular carcinoma. Materials and Methods 1. General Information A total of 46 patients in this group had preoperative abdominal pain, bloating in 26 cases, asymptomatic in 20 cases; preoperative CT examination to determine the specific location and size of liver cancer. The patients were randomly divided into 3 groups: 18 in TAE group, 15 in males and 3 in females, aged 21 to 68 years with an average of 39.6 years; cancer in 3 cases in the left lobe, 3 in the right anterior lobe, and 6 in the right posterior liver.